The clinical trials process is shifting from a manual, site-based approach.
Will you shift with it or be left behind?
Traditional approaches to clinical trials are antiquated. They limit the ability to attract patients – especially those from diverse groups and geographic areas – and make the consent, enrollment, and engagement processes cumbersome, often leading to high drop-out rates and even derailment of the study itself.
Manual data collection and processes lead to errors, inaccurate outcomes and the unacceptable cost to resolve them. The impacts are immeasurable; delayed product launches, lost revenue, and most importantly, the health of those in our communities are all at stake.
If you haven’t made the shift, now is the time.
See how we support the clinical trials of life sciences companies and contract research organizations.
Life Sciences Companies
The pressure is on to bring products to market that diagnose, treat and cure conditions.
Contract Research Organizations (CROs)
Pharmaceutical and other manufacturers are increasingly looking to CROs to manage their clinical trials – with the highest expectations for quality outcomes while still controlling cost.